Boc-Cys(pMeBzl)-OH: A Protected Amino Acid Derivative for Advanced Peptide Synthesis and Drug Discovery

Unlock the potential of peptide synthesis with this crucial amino acid building block for innovative drug development.

Get a Quote & Sample

Key Advantages Provided

Enhanced Synthesis Control

The presence of the Boc protecting group on this amino acid derivative provides chemists with superior control over the synthetic process, minimizing unwanted side reactions and improving overall yield in peptide synthesis.

Improved Peptide Stability

The specific protection offered by the pMeBzl group for the cysteine side chain contributes to the stability of the molecule during synthesis and storage, ensuring reliable results in peptide synthesis.

Versatility in Drug Discovery

This compound is a cornerstone in drug discovery efforts, serving as a versatile intermediate for the synthesis of peptide-based drugs targeting a wide range of diseases.

Key Applications

Peptide Synthesis

Utilized as a fundamental building block in solid-phase and solution-phase peptide synthesis for creating peptides with specific sequences and functionalities, crucial for many peptide synthesis applications.

Drug Development

Plays a critical role in the design and synthesis of novel peptide-based therapeutics, contributing to advancements in drug discovery and development for various medical conditions.

Medicinal Chemistry

Serves as a key intermediate in medicinal chemistry for modifying peptides and developing new drug candidates, often explored for its unique properties in structure-activity relationship studies.

Bioconjugation

Employed in bioconjugation strategies to link peptides to other molecules, facilitating applications in diagnostics, targeted drug delivery, and biomaterial development, making it a valuable bioconjugation reagent.